Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid

被引:56
|
作者
Beard, RL
Colon, DF
Song, TK
Davies, PJA
Kochhar, DM
Chandraratna, RAS
机构
[1] ALLERGAN PHARMACEUT INC, DEPT BIOL, IRVINE, CA 92715 USA
[2] THOMAS JEFFERSON UNIV, DEPT PATHOL ANAT & CELL BIOL, PHILADELPHIA, PA 19107 USA
[3] UNIV TEXAS, SCH MED, DEPT PHARMACOL, HOUSTON, TX 77225 USA
[4] UNIV TEXAS, SCH MED, DEPT MED, HOUSTON, TX 77225 USA
关键词
D O I
10.1021/jm960386h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Retinoids exert their biological effects by binding to and activating nuclear receptors that interact with responsive elements on DNA to promote gene transcription, There are two families of retinoid receptors, the retinoic acid receptor (RAR) family and the retinoid X receptor (RXR) family, which are each further divided into three subclasses: RAR(alpha,beta,gamma) and RXR(alpha,beta,gamma). Herein we describe the synthesis and structure-activity relationships of a new series of diaryl sulfide retinoid analogs that specifically bind and transactivate the RXRs. Furthermore, the sulfoxide and sulfone derivatives of these analogs are partial agonists which activate the RXRs only at high concentrations. Thus, these compounds possess a potential site of metabolic deactivation and may have less prolonged systemic effects than other compounds with arotinoid-like structures. We show also that these compounds have activity in nontransfected cells as demonstrated by their ability to induce TGase activity in HL-60 Cells. Finally, we corroborate our earlier report that RXR-specific agonists may possess reduced teratogenic toxicity compared to RAR-specific agonists since these compounds are much less potent inhibitors of chondrogenesis than RAR-specific agonists such as TTNPB.
引用
收藏
页码:3556 / 3563
页数:8
相关论文
共 50 条
  • [31] Design, synthesis and structure-activity relationships of mangostin analogs as cytotoxic agents
    Chi, Xiao-Qian
    Zi, Cheng-Ting
    Li, Hong-Mei
    Yang, Liu
    Lv, Yong-Feng
    Li, Jin-Yu
    Hou, Bo
    Ren, Fu-Cai
    Hu, Jiang-Miao
    Zhou, Jun
    RSC ADVANCES, 2018, 8 (72): : 41377 - 41388
  • [32] Taxol: Synthesis, Bioactive Conformations, and Structure-Activity Relationships in Its Analogs
    O. N. Zefirova
    E. V. Nurieva
    A. N. Ryzhov
    N. V. Zyk
    N. S. Zefirov
    Russian Journal of Organic Chemistry, 2005, 41 : 315 - 351
  • [33] Synthesis and structure-activity relationships of aliphatic isothiocyanate analogs as antibiotic agents
    Li, Deguang
    Shu, Yanan
    Li, Pingliang
    Zhang, Wenbing
    Ni, Hanwen
    Cao, Yongsong
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (07) : 3119 - 3125
  • [34] Conformationally defined 6-s-trans-retinoic acid analogs .3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity
    Muccio, DD
    Brouillette, WJ
    Alam, M
    Vaezi, MF
    Sani, BP
    Venepally, P
    Reddy, L
    Li, E
    Norris, AW
    SimpsonHerren, L
    Hill, DL
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (19) : 3625 - 3635
  • [36] STRUCTURE-ACTIVITY RELATIONSHIPS OF CYCLIC ACETYLCHOLINE ANALOGS
    MUTSCHLE.E
    ARCHIV DER PHARMAZIE, 1968, 301 (06) : B125 - &
  • [37] Efficient synthesis of cruentaren A and preparation of analogs for the investigation of structure-activity relationships
    Brandt, Gary E. L.
    Blagg, Brian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [38] Structure-activity relationships of semisynthetic mumbaistatin analogs
    Lee, Taek Soon
    Das, Abhirup
    Khosla, Chaitan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) : 5207 - 5218
  • [39] Antibacterial activity and structure-activity relationships of berberine analogs
    Iwasa, K
    Kamigauchi, M
    Ueki, M
    Taniguchi, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1996, 31 (06) : 469 - 478
  • [40] STRUCTURE-ACTIVITY RELATIONSHIPS OF SOME TROXYPYRROLIDINIUM ANALOGS
    CHENIER, LP
    LAM, A
    CHIZ, JF
    MCCOLL, JD
    FEDERATION PROCEEDINGS, 1966, 25 (2P1) : 228 - &